Pretreatment with D-e-MAPP in Slc39a8-IEC KO mice also reduced the expression of inflammation markers, including Cxcl1 and Tnfa, which are hallmarks of ulcerative colitis (Fig. 8i). This evidence concerns the gene CXCL1 and ulcerative colitis.